Anti-Aging Care With Ronacare® Isoquercetin (O/W) MDA-A-20-07

Merck KGaA
Phase
Product
INCI Name
Supplier
Volume
A
Montanov 202
ARACHIDYL ALCOHOL, BEHENYL ALCOHOL, ARACHIDYLGLUCOSIDE
1
3.00
Lanol 99
ISONONYL ISONONANOATE
1
2.00
Miglyol 812 N
CAPRYLIC/CAPRIC TRIGLYCERIDE
2
2.00
Cetiol CC
DICAPRYLYL CARBONATE
3
3.00
Cocoate BG
BUTYLENE GLYCOL COCOATE
4
2.00
B
Complexing agent (q.s.)
qs
Preservatives (q.s.)
qs
Water, demineralized
ad 100
C
Simulgel NS
HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYLTAURATE COPOLYMER, SQUALANE, POLYSORBATE 60
1
2.00
D
RonaCare® Isoquercetin
ISOQUERCETIN
5
0.30
1.2-Propanediol
PROPYLENE GLYCOL
5
10.00

Preparation:

Combine phases A and B seperately and heat to 80°C. Add phase A to phase B while stirring. Homogenize. Add phase C at ~ 60°C. Add dissolved phase D (warm up to 40-50°C). Add phase E at 40°C. Adjust pH to 5.0-5.5.

Notes:

Aspect: Yellowish soft creampH value (22°C): 5.4Viscosity: 22000 mPa.s (Brookfield model DV- II+, Helipath spindle C, 10 rpm) at 22°C Suppliers: (1) Seppic (2) Sasol Germany GmbH (3) BASF AG (4) Gattefossé GmbH (5) Merck KGaA, Darmstadt, Germany / EMD Chemicals
Disclaimer

While every effort has been made to reproduce these formulations correctly, the Publisher of this website cannot accept any liability for the information presented. All formulations are provided in good faith, but no warranty is given as to accuracy of information or results, or suitability for a particular use, nor is freedom from patent infringement to be inferred. Formulations are offered solely for consideration by the participating manufacturers. Continued use of this web site infers acceptance of this disclaimer.

Latest Issues

IFSCC 2024

Recanto das Cataratas Thermas Resort, Iguazu Falls, Brazil
14th - 17th October 2024

SEPAWA

Estrel Congress Center, Berlin
16th - 18th October 2024